● Recruiting

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen

Condition: Rhinitis, Allergic · Rhinoconjunctivitis · Asthma, Allergic · Sponsor: Inmunotek S.L.

PhasePhase 3

Planned participants180

Who can joinAll sexes, 12 Years to 65 Years

Healthy volunteersNo

About this study

Prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial of efficacy and safety with subcutaneous immunotherapy in patients with mild to moderate rhinitis / rhinoconjunctivitis with or without mild to moderate asthma sensitized to grasses and olive

This description comes directly from the study's public registry record.

Talk to the study team

Miguel Casanovas · 912908942 · mcasanovas@inmunotek.com

Raquel Caballero · 607600638 · rcaballero@inmunotek.com

Always discuss trial participation with your own doctor first.

Locations (32)

Cedt de Tarancón	Tarancón, Cuenca, Spain	Recruiting
Hospital Universitario Principe de Asturias	Alcalá de Henares, Madrid, Spain	Completed
Centro Médico Iza	Tres Cantos, Madrid, Spain	Recruiting
Hospital Infanta Elena	Valdemoro, Madrid, Spain	Recruiting
Hospital Clínico Universitario Virgen de Arrixaca	El Palmar, Murcia, Spain	Recruiting
Private Practice	Albacete, Spain	Withdrawn
Hospital Ntra. Sra. de Sonsoles	Ávila, Spain	Recruiting
Clinica Dermatologica Y Alergia	Badajoz, Spain	Recruiting
Hospital Quironsalud Clideba	Badajoz, Spain	Recruiting
Hospital Universitario Dexeus	Barcelona, Spain	Recruiting
Clínica privada Barcelona	Barcelona, Spain	Withdrawn
Hospital General Universitario Ciudad Real	Ciudad Real, Spain	Recruiting

+ 20 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04891237